Early Cellular and Humoral Responses Developed in Oncohematological Patients after Vaccination with One Dose against COVID-19 is a research paper published in Journal of Clinical Medicine (2022). On theSindex it has a DataRank of 0.292. It has been cited 6 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.292
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Chiesi España, S.A.U. (Barcelona, Spain)
Grant: R01AI143567
Chiesi España, S.A.U. (Barcelona, Spain)
Grant: PID2019-110275RB-I00
Chiesi España, S.A.U. (Barcelona, Spain)
Grant: FIS PI16CIII/00034-ISCIII-FEDER
Chiesi España, S.A.U. (Barcelona, Spain)
Grant: ISCIII-PFIS FI20CIII/00021
Chiesi Foundation
Grant: Donation
Instituto de Salud Carlos III
Grant: COV20_00679
Instituto de Salud Carlos III
Grant: PI21/00877
National Institutes of Health
Grant: 5R01AI143567-03
Tyrosine Kinase inhibition: The New Front in HIV Cure Efforts
Hematology and Hemotherapy Service of the Hospital Universitario Ramón y Cajal
Chiesi España, S.A.U.
FWCI
0.58
Citation Percentile
0.6%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals